NORTHWEST INVESTMENT COUNSELORS, LLC - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 119 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 7.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHWEST INVESTMENT COUNSELORS, LLC ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,903
-35.1%
7500.0%0.00%0.0%
Q2 2023$4,470
+82.2%
7500.0%0.00%0.0%
Q1 2023$2,453
-17.2%
7500.0%0.00%0.0%
Q4 2022$2,9637500.00%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Trustees of Columbia University in the City of New York 281,250$6,334,0009.69%
Flagship Pioneering Inc. 34,239,018$771,063,0008.08%
Crestline Management, LP 3,210,937$72,310,0006.80%
SB Management Ltd 2,209,004$49,747,0005.10%
Omega Fund Management, LLC 843,750$19,001,0002.13%
HARVARD MANAGEMENT CO INC 1,163,601$26,204,0001.54%
Alphabet Inc. 2,812,500$63,338,0001.50%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 387,508$8,727,0001.03%
PUBLIC SECTOR PENSION INVESTMENT BOARD 4,131,249$93,036,0000.53%
Dragoneer Investment Group 1,500,000$33,780,0000.44%
View complete list of SANA BIOTECHNOLOGY INC shareholders